GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 271 filers reported holding GLOBUS MED INC in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,804,000 | +55.9% | 30,641 | +35.3% | 0.05% | +78.6% |
| Q3 2019 | $1,157,000 | -30.3% | 22,641 | -40.9% | 0.03% | -34.9% |
| Q4 2018 | $1,659,000 | +9.6% | 38,326 | +42.4% | 0.04% | +34.4% |
| Q3 2018 | $1,513,000 | +10.3% | 26,910 | -2.3% | 0.03% | +10.3% |
| Q1 2018 | $1,372,000 | -43.5% | 27,538 | -66.3% | 0.03% | -38.3% |
| Q3 2017 | $2,430,000 | -52.2% | 81,729 | -46.7% | 0.05% | -53.5% |
| Q2 2017 | $5,085,000 | +40.0% | 153,386 | +25.1% | 0.10% | +13.5% |
| Q1 2017 | $3,633,000 | +101.3% | 122,658 | +68.6% | 0.09% | +39.1% |
| Q4 2016 | $1,805,000 | +784.8% | 72,767 | +705.2% | 0.06% | +966.7% |
| Q3 2016 | $204,000 | -97.2% | 9,037 | -97.0% | 0.01% | -96.2% |
| Q4 2014 | $7,209,000 | +1797.1% | 301,183 | +1464.1% | 0.16% | +1666.7% |
| Q3 2014 | $380,000 | -78.5% | 19,256 | -71.0% | 0.01% | -82.4% |
| Q1 2014 | $1,767,000 | +38.2% | 66,462 | +4.8% | 0.05% | +59.4% |
| Q4 2013 | $1,279,000 | – | 63,397 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |